- Home
- MIST vs ACR Comparison
MIST vs ACR Comparison
Compare MIST & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | ACR |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.3M | 146.1M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MIST | ACR |
|---|---|---|
| Price | $1.04 | $14.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.00 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 1.7M | 32.1K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $79,946,000.00 |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $13.83 |
| 52 Week High | $3.06 | $24.61 |
Technical Indicators
Market Signals| Indicator | MIST | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 39.32 | 39.29 |
| Support Level | $1.01 | $13.83 |
| Resistance Level | $1.42 | $18.56 |
| Average True Range (ATR) | 0.07 | 0.70 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 7.41 | 55.11 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.